News items related to: News
-
Indonesian Advocates Challenge Big Pharma’s Patent of HIV Prevention and Treatment Lenacapavir
Indonesia AIDS Coalition (IAC), a community-based organization advocating on HIV-related issues, filed a post-grant opposition against the secondary (selection) patent...
-
Patent Applications for HIV Prevention Drug Opposed in India: Vulnerable Group Seeks to Protect Generic Competition to Lower Prices of HIV Prevention Drug Lenacapavir
New Delhi, 18 September 2024 – The Indian Patent Office is set to hear the objections of Sankalp Rehabilitation Trust...
-
HIV Community-Based Organizations are Fighting Patent Monopolies on Lenacapavir
Despite the world’s efforts, there have been over a million new cases of HIV each year. Lenacapavir (LEN), a long-acting...
-
Ending the Epidemic Could Cost Under $40 (per person, per year) – treatment activists say at AIDS2024
Munich, 23 July 2024 – Despite global efforts to end HIV and AIDS, the epidemic has been persistent. In 2022,...
-
Activists at AIDS2024 called on ViiV Healthcare to drop their case in Colombia against Compulsory License on Dolutegravir
On the 24th of July, hundreds of treatment advocates attending AIDS2024 in Munich protested against the companies with “Drop The...
-
Activists block big pharma patent on COVID-19 pill in Russia, but fight not over
Russia’s patent office made a ground-breaking decision to reject a patent application for molnupiravir, a treatment for COVID-19, which was...
-
The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy
The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB)...
-
Brazilian Community-Based Organization ABIA Bids to Expand HIV Treatment Access by Overriding the Patent on Dolutegravir
The Brazilian Interdisciplinary AIDS Association (ABIA), an advocacy group in Rio de Janeiro, has called on the Ministry of Health...
-
Researchers Reveal Strategies Used by Big Pharma to Monopolize COVID-19 Drugs and Vaccines
Pharmaceutical companies took advantage of the COVID-19 pandemic, ensuring maximum profits and monopolies on life-saving vaccines and drugs, according to...
-
FGEP Files Pre-Grant Patent Opposition for Covid Vaccine Against Pfizer
Fundación Grupo Efecto Positivo (FGEP) has filed a pre-grant patent opposition in a bid to make COVID-19 vaccines accessible and...
-
Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
Activists from Morocco, Thailand, and Vietnam have filed patent oppositions to challenge drug manufacturers Incyte and Eli Lilly over the...
-
J & J’s Deal With the Global Drug Facility Disguises the Continued Issue with Access to Bedaquiline to Treat Drug-Resistant Tuberculosis
“This deal is big step backwards for global public health – it allows J & J to keep selling higher-priced...